Does Rallies show 13F holders for LLY?

Yes. Rallies tracks hedge fund and 13F ownership data for LLY, including fund names, share counts, latest tracked quarter, and position changes when available.

Is LLY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LLY. It does not provide personalized investment advice.

LLY (Eli Lilly) Stock Analysis - Hedge Fund Holdings

Eli Lilly (LLY) is a publicly traded Healthcare sector company. As of May 20, 2026, LLY trades at $1,018.50 with a market cap of $881.12B and a P/E ratio of 43.77. LLY moved -0.53% today. Year to date, LLY is -5.46%; over the trailing twelve months it is +35.27%. Its 52-week range spans $623.78 to $1,133.95. Analyst consensus is strong buy with an average price target of $1,262.85. Rallies surfaces LLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns LLY stock?

Hedge funds tracked by Rallies that own LLY include Tiger Global, Polen Capital, Viking Global, Panagora Asset, and Orbimed Advisors. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Eli Lilly.

LLY Key Metrics

Key financial metrics for LLY
Metric	Value
Price	$1,018.50
Market Cap	$881.12B
P/E Ratio	43.77
EPS	$23.00
Dividend Yield	1.73%
52-Week High	$1,133.95
52-Week Low	$623.78
Volume	2.02M
Avg Volume	0
Revenue (TTM)	$65.18B
Net Income	$20.64B
Gross Margin	83.04%

Top Hedge Funds Holding LLY

Tiger Global holds 1.51M shares of LLY, changed +13.20% as of Jun 30, 2025.
Polen Capital holds 914.56K shares of LLY, changed -26.61% as of Mar 31, 2026.
Viking Global holds 416.92K shares of LLY, changed +174.22% as of Jun 30, 2025.
Panagora Asset holds 322.68K shares of LLY, changed -4.50% as of Mar 31, 2026.
Orbimed Advisors holds 236.80K shares of LLY, changed -21.38% as of Mar 31, 2026.

Latest LLY News

Eli Lilly Sues Church Leaders Over $200M Trulicity Rebate Fraud — May 20, 2026
Supreme Court Upholds Qui Tam Suits and Zepbound Trails Wegovy 1.5x — May 18, 2026
Lilly Commits $50M to UNICEF Partnership, Launches Oral GLP-1 Pill Foundayo — May 14, 2026
Foundayo Regains Only 0.9 kg in 52 Weeks; Zepbound MTD Preserves 100% Loss — May 12, 2026
Alzheimer’s Blood Test Wins CE Mark as Obesity IPO Targets Lilly’s GLP-1 Lead — May 12, 2026

Recent LLY Insider Trades

LILLY ENDOWMENT INC sold 895 (~$971.17K) on Jan 7, 2026.
LILLY ENDOWMENT INC sold 7.68K (~$8.35M) on Jan 7, 2026.
LILLY ENDOWMENT INC sold 1.07K (~$1.16M) on Jan 7, 2026.

LLY Analyst Consensus

22 analysts cover LLY: 0 strong buy, 19 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,262.85.

Common questions about LLY

Who owns LLY stock?: Hedge funds tracked by Rallies that own LLY include Tiger Global, Polen Capital, Viking Global, Panagora Asset, and Orbimed Advisors. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Eli Lilly.
Does Rallies show 13F holders for LLY?: Yes. Rallies tracks hedge fund and 13F ownership data for LLY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is LLY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LLY. It does not provide personalized investment advice.